High incidence of cetuximab-related infusion reactions in head and neck patients

BACKGROUND: Cetuximab is crucial in the management of squamous cell carcinoma of the head and neck of patients. Grade 3–4 cetuximab-induced infusion reactions (CI-IRs) occur in 2% of patients with colorectal cancer. Despite the 2.7% CI-IR rate in the EXTREME trial, higher rates were reported in smal...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESMO Open
Hlavní autoři: Palomar Coloma, Virginia, Bravo, Pamela, Lezghed, Naima, Mayache-Badis, Lamia, Herrera Gómez, Ruth Gabriela, Iacob, Mariana, Nicouleau, Laurence, Desmaris, Romain, Tao, Yungan, Leibu, Cristian, Matias, Margarida, Lemare, Francois, Even, Caroline, Annereau, Maxime, Ferté, Charles
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6069910/
https://ncbi.nlm.nih.gov/pubmed/30094066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000346
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky